Cooper, P J <br/><br/>
Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin.  [electronic resource] 

 -  The Journal of infectious diseases  Mar 1999 
 - 738-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1086/314647  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Agranulocytosis--chemically induced<br/>Animals<br/>Anthelmintics--adverse effects<br/>Cell Degranulation--drug effects<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Eosinophils--drug effects<br/>Ghana<br/>Humans<br/>Interleukin-5--blood<br/>Ivermectin--adverse effects<br/>Male<br/>Onchocerca volvulus<br/>Onchocerciasis--drug therapy<br/>Placebos